{"id":"https://openalex.org/W2334530071","doi":"https://doi.org/10.1158/1538-7445.am2012-4552","title":"Abstract 4552: Utilization of pathway activation and somatic mutation analysis in combination in fine needle aspirates to identify candidate drugs for effective treatment of breast cancer","display_name":"Abstract 4552: Utilization of pathway activation and somatic mutation analysis in combination in fine needle aspirates to identify candidate drugs for effective treatment of breast cancer","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2334530071","doi":"https://doi.org/10.1158/1538-7445.am2012-4552","mag":"2334530071"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-4552","doi":"https://doi.org/10.1158/1538-7445.am2012-4552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045596163","display_name":"Tani Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tani Lee","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015856041","display_name":"Phillip S. Kim","orcid":"https://orcid.org/0000-0003-0249-078X","observed_orcids":["https://orcid.org/0000-0003-0249-078X"]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip S. Kim","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001696653","display_name":"Gulia Harvie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gulia Harvie","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039850816","display_name":"Gary E. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Meyer","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088855583","display_name":"Glen D. Leesman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glen Leesman","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086614659","display_name":"Emma J. Langley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma Langley","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100388544","display_name":"Limin Liu","orcid":"https://orcid.org/0000-0003-2527-7201","observed_orcids":["https://orcid.org/0000-0003-2527-7201"]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Limin Liu","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039987032","display_name":"Hicholas Hoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hicholas Hoe","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024257180","display_name":"Fred Princen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fred Princen","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063978256","display_name":"Fabiyola M. Selvaraj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabiyola Selvaraj","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xinjun Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xinjun Liu","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080135700","display_name":"Sharat Singh","orcid":"https://orcid.org/0000-0001-8707-4317","observed_orcids":["https://orcid.org/0000-0001-8707-4317"]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharat Singh","raw_affiliation_strings":["1Prometheus Lab, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prometheus Lab, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210094228"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"4552","last_page":"4552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.301800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.301800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.2484000027179718,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.22280000150203705,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fine-needle-aspirate","display_name":"fine needle aspirate","score":0.7559999823570251},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pathway-activation","display_name":"pathway activation","score":0.5360000133514404},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.6549999713897705},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9480000138282776},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.8759999871253967},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7870000004768372},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8460000157356262},{"id":"https://openalex.org/keywords/therapeutic-target-selection","display_name":"therapeutic target selection","score":0.5299999713897705},{"id":"https://openalex.org/keywords/her2-positive","display_name":"HER2-positive","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5633054375648499},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5596691370010376},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5393436551094055},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.535930335521698},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.5288846492767334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5198274254798889},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5171082019805908},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.4559493660926819},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.4470064640045166},{"id":"https://openalex.org/C144174609","wikidata":"https://www.wikidata.org/wiki/Q14901457","display_name":"Insulin-like growth factor 1 receptor","level":4,"score":0.43742966651916504},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4267506003379822},{"id":"https://openalex.org/C163565370","wikidata":"https://www.wikidata.org/wiki/Q4308623","display_name":"Mutation testing","level":4,"score":0.4168047606945038},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4065142869949341},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3829970359802246},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3609517812728882},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.359374463558197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29234448075294495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2881593108177185},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1976582407951355},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1401674449443817},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09400048851966858},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-4552","doi":"https://doi.org/10.1158/1538-7445.am2012-4552","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4552","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590365375","https://openalex.org/W2883882459","https://openalex.org/W2232746135","https://openalex.org/W2604160575","https://openalex.org/W2900626521","https://openalex.org/W2554152655","https://openalex.org/W2319634551","https://openalex.org/W2977594222","https://openalex.org/W370019","https://openalex.org/W2160089679"],"abstract_inverted_index":{"Abstract":[0],"A":[1,86,232,269],"critical":[2],"hurdle":[3],"in":[4,10,150,167,172,200,219,266,295],"implementing":[5],"prognostic":[6],"and":[7,62,77,105,121,192,287],"predictive":[8],"biomarkers":[9,218],"clinical":[11,28,267,296],"trials":[12],"is":[13],"our":[14],"inability":[15],"to":[16,97],"perform":[17],"an":[18],"efficient":[19],"molecular":[20,35],"characterization":[21],"of":[22,26,37,47,57,101,117,146,152,169,179,206,217,242,256,259,306,311],"the":[23,99,114,126,170,307,312],"limited":[24],"amounts":[25],"available":[27],"samples.":[29],"Here":[30],"we":[31],"report":[32],"a":[33,284],"comprehensive":[34,233],"analysis":[36,54,116,272],"fine":[38],"needle":[39],"aspirate":[40],"(FNA)":[41],"samples":[42,171],"collected":[43,132,154],"from":[44,128,133,155],"metastatic":[45,129],"sites":[46,130],"58":[48],"breast":[49],"cancer":[50],"(BCA)":[51],"patients.":[52],"The":[53],"included":[55],"interrogation":[56],"key":[58],"receptor":[59],"tyrosine":[60],"kinases":[61],"their":[63],"downstream":[64],"signaling":[65],"molecules":[66],"including":[67],"HER1,":[68,189],"HER2,":[69,190],"p95HER2,":[70],"HER3,":[71],"cMET,":[72],"IGF1R,":[73],"PI3K,":[74],"Shc,":[75],"AKT":[76],"ERK":[78,182],"as":[79,81,186,188,227,229],"well":[80,187,228],"oncogenic":[82],"somatic":[83,122],"mutational":[84,286],"profiling.":[85],"multiplexed":[87,118,270],"immunoarray":[88],"CEER\u2122":[89],"(Collaborative":[90],"Enzyme":[91],"Enhanced":[92],"Reactive-immunoassay)":[93],"platform":[94],"was":[95,148],"utilized":[96],"determine":[98],"levels":[100,178],"pathway":[102,119,213,225,261,271,288],"protein":[103,249],"expression":[104],"phosphorylation.":[106],"All":[107,125],"FNA":[108,127],"collections":[109],"provided":[110],"sufficient":[111],"materials":[112],"for":[113,315],"combined":[115,285],"expression/activation":[120],"mutation":[123,230],"analysis.":[124,231],"(mFNA)":[131],"HER2":[134,147,159],"positive":[135],"primary":[136,161],"tumors":[137],"(determined":[138],"by":[139],"IHC)":[140],"were":[141,165,198],"also":[142,210,274],"CEER-HER2":[143],"positive.":[144],"Over-expression":[145],"found":[149,166,199],"10%":[151],"mFNAs":[153,201],"BCA":[156,220],"patients":[157,209,221],"with":[158,202],"negative":[160],"tumors.":[162],"PIK3CA":[163,203,207],"mutations":[164],"20%":[168],"this":[173],"cohort.":[174],"Statistically":[175],"significant":[176],"higher":[177],"phosphorylated":[180],"AKT,":[181],"(downstream":[183],"effector":[184],"targets)":[185],"HER3":[191],"IGF1R":[193],"(PI3K":[194],"membrane":[195],"recruiter":[196],"proteins)":[197],"mutations.":[204],"Subset":[205],"wildtype":[208],"showed":[211],"robust":[212],"signature.":[214],"Hence,":[215],"evaluation":[216],"should":[222],"include":[223],"both":[224],"proteins":[226],"disease":[234],"profiling":[235,262,290],"can":[236,263,273,291],"provide":[237,275],"insightful":[238],"information":[239,277],"on":[240,245],"efficacy":[241],"specific":[243],"agents":[244],"its":[246],"intended":[247],"target":[248],"inhibition.":[250],"As":[251],"CEER":[252],"requires":[253],"minimal":[254],"amount":[255],"specimen,":[257],"performance":[258],"routine":[260],"be":[264],"achieved":[265],"settings.":[268],"valuable":[276],"about":[278],"potential":[279],"drug":[280],"resistance":[281],"mechanisms.":[282],"Furthermore,":[283],"activation":[289],"guide":[292],"therapeutic":[293],"strategies":[294],"setting.":[297],"Citation":[298],"Format:":[299],"{Authors}.":[300],"{Abstract":[301],"title}":[302],"[abstract].":[303],"In:":[304],"Proceedings":[305],"103rd":[308],"Annual":[309],"Meeting":[310],"American":[313],"Association":[314],"Cancer":[316,327],"Research;":[317],"2012":[318],"Mar":[319],"31-Apr":[320],"4;":[321],"Chicago,":[322],"IL.":[323],"Philadelphia":[324],"(PA):":[325],"AACR;":[326],"Res":[328],"2012;72(8":[329],"Suppl):Abstract":[330],"nr":[331],"4552.":[332],"doi:1538-7445.AM2012-4552":[333]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}